Japan approves Moderna COVID-19 vaccine

By The Science Advisory Board staff writers

Japan's Ministry of Health, Labour, and Welfare recently approved Moderna's COVID-19 vaccine, and distribution in the country by Takeda will begin immediately.

The approval is based on Moderna's phase III Coronavirus Efficacy (COVE) study results and positive initial clinical data from the Takeda-led placebo-controlled phase III study.

Takeda and Moderna previously announced that Takeda will import and distribute 50 million doses of Moderna's COVID-19 vaccine candidate starting in the first half of 2021. The companies have affirmed discussions reported recently for an additional potential supply of 50 million doses from the beginning of 2022.

Copyright © 2021 scienceboard.net

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a Scienceboard.net password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?